2 cheap UK stocks to buy for the rotation into value

Right now, we’re seeing a huge rotation from growth stocks to value stocks. Edward Sheldon highlights two UK shares he’d buy to benefit from this shift.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Right now, we’re seeing a huge shift in the stock market. With interest rates rising, investors all over the world are moving their money from ‘growth’ shares to ‘value’ shares. This shift is benefiting the UK market. That’s because the London Stock Exchange is home to many value stocks.

While there’s no guarantee value will continue to outperform growth, I like the idea of owning a few cheap stocks to capitalise on the rotation into the former. With that in mind, here’s a look at two UK value stocks I’d be happy to take small positions in today.

A dirt-cheap FTSE 100 stock

Let’s start with private equity and infrastructure investment firm 3i Group (LSE: III), which is a member of the FTSE 100 index. This stock looks very cheap right now. Currently, its forward-looking price-to-earnings (P/E) ratio is just 5.9.

I’m bullish on this value stock for a couple of reasons. Firstly, the company appears to have plenty of momentum right now. In a recent performance update, the group said it generated a total return of 33% from portfolios in the nine months to 31 December 2021. It also said it’s set for a “strong close” to its financial year ending 31 March 2022.

Secondly, in the second half of 2021, there were some big insider buys here from top-level executives within the company. Insiders only buy company stock for one reason – they expect it go up.

One risk to consider here is that revenues and profits can fluctuate. This can result in share price weakness at times.

Overall however, I think the risk/reward is attractive right now. The stock is cheap and there’s a dividend yield of around 3% on offer.

It’s worth noting that analysts at Barclays just raised their target price to 1,840p, which is nearly 40% above the current share price.

A value stock offering growth and dividends

Another UK value stock I’d snap up today is Hikma Pharmaceuticals (LSE: HIK). It’s an under-the-radar healthcare company that manufactures generic, branded, and injectable medicines. At present, the stock has a forward-looking P/E ratio of about 12.2, which is well below market average.

There’s a lot to like about Hikma, in my view. For starters, the company has a solid growth track record. Between 2015 and 2020, revenue climbed from $1.4bn to $2.3bn. For 2021, analysts expect revenue of $2.5bn.

Secondly, the company is very profitable (three-year average return on capital of 18%) and it has been growing its dividend at a very healthy rate in recent years. For 2021, analysts expect a payout of 53.5 cents per share, which equates to a yield of around 2% at the current share price.

A risk to consider is acquisitions. Hikma has made a number of them in the past and they haven’t always gone to plan. This could happen again.

I’m comfortable buying the stock at current levels however, as I think the low valuation provides a margin of safety.

And I’ll point out I’m not the only one who is bullish here. Last month, analysts at Peel Hunt upgraded the stock from ‘hold’ to ‘buy’, saying the generic medicine maker’s business and prospects are “under-appreciated” at its current share price.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Edward Sheldon has no position in any of the shares mentioned. The Motley Fool UK has recommended Barclays and Hikma Pharmaceuticals. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »